Britain’s competition regulator has fined more than 10 drug firms a record combined £260 million ($360 million) for overcharging the National Health Service (NHS) for a steroid that rose from 70 pence to £88 a pack in under eight years. The Competition and Markets Authority (CMA) said on Thursday that the breaches meant the NHS…